Unique EnCapsulation Technology LLC
Letter data
- Company
- Unique EnCapsulation Technology LLC
- Recipient
- K.G. Rao | Founder & CEO | Unique EnCapsulation Technology LLC | 9 Lenel Road | Landing | , | NJ | 07850 | United States
- Issue date
- 2019-02-08
- Posted date
- Not available
- FDA office
- Center for Food Safety and Applied Nutrition
- Subject
- Not available
- Product
- Food & Beverages
- CMS ID
- 506356
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Unique EnCapsulation Technology LLC
MARCS-CMS 506356 —
February 08, 2019
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Product:
Food & Beverages
Recipient:
Recipient Name
K.G. Rao
Recipient Title
Founder & CEO
Unique EnCapsulation Technology LLC
9 Lenel Road
Landing
,
NJ
07850
United States
Issuing Office:
Center for Food Safety and Applied Nutrition
6000 Metro Drive
Suite 101
Baltimore
,
MD
21215
United States
(410) 779-5455
Dear Mr. Rao,
On November 8, 2018, the Food and Drug Administration completed an evaluation of your firm’s corrective actions in response to our Warning Letter (#506356) dated January 17, 2017. Based on our evaluation of your most recent inspection that was concluded November 8, 2018, it appears that you have addressed the violations contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. If you have any questions related to this letter, I can be contacted via email at
rochelle.young@fda.hhs.gov
or by phone at 410-779-5437.
Sincerely,
/S/
CDR Rochelle B. Young, RPh. MSA
Office of Human & Animal Food East Division 2
Compliance Officer
Content current as of:
05/15/2019
Regulated Product(s)
Food & Beverages